Corn Peptide Nanoparticle Shields Liver Cells From Alcohol Damage in Lab Study

The nanoparticles, described in a study published in Frontiers in Nutrition, boosted the survival of human liver cells exposed to ethanol from 48.87 percent to 75.18 percent, while simultaneously dampening the burst of reactive oxygen molecules that alcohol metabolism unleashes inside cells. The work is at an early stage — everything was done in cultured cells rather than living animals — but it offers a technically elegant answer to a long-standing problem in nutraceutical delivery: how to get fragile, health-promoting peptides past the harsh chemistry of the digestive tract and into the specific organ where they are needed. The active ingredient at the heart of the system is corn peptide, a mixture of small bioactive polypeptides produced by enzymatically hydrolyzing corn protein meal.

Corn peptides have a track record in this space; they were authorized as a new food resource in China back in 2010, and they have traditionally been used for hangover relief and liver support. Their protective repertoire extends beyond the liver, with reported antioxidant, blood pressure-lowering, blood glucose-regulating, and lipid-reducing activities, effects the researchers attribute largely to their abundant leucine and alanine residues. Yet like many food-derived bioactives, corn peptides suffer from a pharmacological Achilles heel: poor acid stability, vulnerability to enzymatic digestion, rapid systemic clearance, a short half-life in the body, and consequently low oral bioavailability.

A compound that works brilliantly in a test tube may simply never reach the liver in meaningful quantities after being swallowed. In the Maillard reaction, amino groups on proteins react with carbonyl groups on reducing sugars, forming covalent protein-sugar conjugates without the need for any external chemical catalyst. Because it is food-grade and naturally occurring, the reaction is an attractive tool for modifying edible ingredients.

The researchers had previously used a similar strategy to couple sea cucumber peptides with galactose, a formulation that improved the water solubility and bioavailability of the liver-protective compound silymarin. The sugar chosen this time was galactooligosaccharide, or GOS, and the choice was deliberate rather than incidental. The surface of hepatic parenchymal cells — the working cells of the liver — is studded with a receptor called the asialoglycoprotein receptor, or ASGPR, which specifically recognizes galactose.

Galactosylated molecules are therefore bound by ASGPR and preferentially directed to liver tissue. By grafting GOS onto corn peptides, the team hoped to accomplish two things at once: shield the fragile peptides from degradation and give the resulting particles a molecular passport that hepatocytes would recognize and internalize. The concept of liver-targeted delivery generally relies on exactly this kind of receptor-ligand interaction to prolong the retention of active compounds in the organ.

Synthesis was carried out by a wet Maillard reaction. Corn peptides and GOS were dispersed together in ultrapure water at various mass ratios — 1:1, 1:2, 2:1, and 4:1 — stirred at 25 degrees Celsius, and then incubated at 80 degrees Celsius for periods ranging from zero to eight hours. The reaction was stopped by plunging the samples into ice water, after which they were freeze-dried and stored in the dark.

To track how far the reaction had progressed, the researchers used the o-phthalaldehyde assay to measure free amino groups, calculating a degree of glycation. The maximum grafting degree, 36.48 percent, was achieved with a corn peptide to GOS ratio of 4:1 after eight hours of reaction. Browning indices measured at 294 and 420 nanometers rose over time, marking the accumulation of intermediate and final Maillard products, while the intrinsic fluorescence of the corn peptides faded as the sugar grafts masked it.

A battery of structural and physical analyses confirmed that the conjugation had genuinely occurred. Fourier transform infrared spectroscopy showed that, after coupling, the amide I band and the C-O-C antisymmetric stretching band shifted to 1,672 and 1,028 inverse centimeters respectively — signatures consistent with the initial formation of Schiff bases and glycosylamine in the Maillard reaction, and with anionic GOS being grafted onto the peptides. X-ray diffraction of grafts made at different reaction times all showed a broad peak near 2θ = 19 degrees, indicative of an amorphous structure.

Zeta potential measurements traced an interesting arc: the absolute value of the surface charge first rose, consistent with electrostatic interaction between the two components, then fell at later reaction times as the covalent complex shielded the peptide surface. Stability and antioxidant performance both improved markedly after glycosylation. Over 28 days of storage at 4 degrees Celsius in the dark, the conjugates showed no visible precipitation, aggregation, or discoloration, and differential scanning calorimetry pointed to a stable network held together by hydrogen bonding along with electrostatic and hydrophobic interactions.

Antioxidant capacity was assessed with four independent assays. In the DPPH assay, mean free radical scavenging activity rose from 24.51 percent for pure corn peptides to 76.19 percent for the conjugate after eight hours of reaction. The ABTS assay showed an increase from 26.22 percent to 72.61 percent, hydroxyl radical scavenging climbed from 26.88 percent to 72.69 percent, and reducing power, tracked spectrophotometrically at 700 nanometers, rose from an absorbance of 0.51 to 0.72.

The researchers attribute these gains to the covalent bonds reducing intermolecular hydrogen bonding among the peptides and to the formation of reactive aromatic structures such as pyrrole and thiophene during the Maillard reaction, which promote electrophilic addition reactions that neutralize radicals. The cellular experiments then put the particles to the test against alcohol itself. Using LO2 cells, a human hepatocyte cell line, the team first checked safety: after 12 hours of exposure to the nanoparticles at 160 micrograms per milliliter, cell viability remained above 90 percent for the eight-hour conjugate, and longer reaction times were associated with lower cytotoxicity.

Calcein-AM/PI staining, which labels live cells green and dead cells red, showed fluorescence patterns closely resembling untreated controls. When the cells were then injured with 0.8 molar ethanol for 12 hours, viability collapsed to 48.87 percent of control levels. Treatment with the eight-hour CPs-GOS nanoparticles rescued viability in a dose-dependent manner — to 55.29 percent at the low dose of 40 micrograms per milliliter, 69.57 percent at the medium dose of 80, and 75.18 percent at the high dose of 160.

Fluorescence staining mirrored the MTT results, with ethanol-treated cells glowing intensely red and nanoparticle-treated cells showing progressively less death signal at higher doses. Two further experiments illuminated how the protection works. First, FITC-labeled nanoparticles were visibly internalized by LO2 cells in a time-dependent manner between two and four hours, a finding confirmed by flow cytometry.

The researchers attribute this uptake to the galactosyl moieties on the particle surface being recognized by ASGPR, which is highly expressed on hepatocyte membranes. Second, using the ROS-sensitive fluorescent probe DCFH-DA, they showed that ethanol exposure drove a pronounced rise in intracellular reactive oxygen species, and that nanoparticle treatment reduced those levels in a concentration-dependent manner. This matters because reactive oxygen species sit at the center of ethanol-mediated cell damage: after alcohol exposure, ROS levels rise abnormally, overwhelming the antioxidant system and promoting oxidative degradation of proteins and lipids, DNA strand breaks, and loss of mitochondrial membrane potential, ultimately progressing to cell death.

By scavenging excess ROS, the particles appear to interrupt this cascade at its source. Biocompatibility was probed with a hemolysis assay using defibrinated sheep red blood cells. Across concentrations from 0.25 to 2 milligrams per milliliter and incubation periods of one and three hours, the nanoparticles caused no detectable hemolysis, with quantitative hemolysis ratios of just 0.06 to 0.14 percent.

The authors are careful about the limits of their work: the entire study was conducted in vitro, with commercially available established cell lines, and no animal or human data exist yet. They state that subsequent research will focus on live animal models to determine the biodistribution of fluorescently labeled nanoparticles and to validate the safety profile following oral administration, along with in vivo liver-specific targeting and therapeutic efficacy in models of alcoholic liver disease. Alcoholic liver disease remains among the predominant chronic hepatic diseases worldwide, progressing silently from fatty liver through inflammation and fibrosis to often-irreversible cirrhosis, so a food-grade, receptor-targeted delivery platform built from two edible ingredients — if it survives the journey from dish to organism — would represent a genuinely appealing addition to a field with few options.

Subject of Research: A hepatocyte-targeted corn peptide–galactooligosaccharide nanoparticle tested against ethanol-induced damage in cultured liver cells

Article Title: A hepatocyte targeted corn peptide—galactooligosaccharide nanoparticle for the alleviation of ethanol-induced damage in cells

Article References: Zhou, M., Jiang, X., Li, C., Wang, Y., & Hao, S. (2026). A hepatocyte targeted corn peptide—galactooligosaccharide nanoparticle for the alleviation of ethanol-induced damage in cells. Frontiers in Nutrition, 13, Article 1987391. https://doi.org/10.3389/fnut.2026.1987391

Image Credits: AI Generated

DOI: 10.3389/fnut.2026.1987391

Keywords: corn peptides, galactooligosaccharides, nanoparticles, Maillard reaction, alcoholic liver disease, hepatocyte targeting, ASGPR, oxidative stress, reactive oxygen species, LO2 cells, antioxidant activity, drug delivery